J7333 — Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
J7333 is a HCPCS Level II code for hyaluronan or derivative, visco-3, for intra-articular injection, per dose. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on March 31, 2021 and is not valid on new claims.
This code has been terminated
CMS terminated J7333 on March 31, 2021. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7333
- Long descriptor
- Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
- Short descriptor
- Visco-3 inj dose
- Added
- July 1, 2020
- Terminated
- March 31, 2021
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7333
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7333 is not quite right, the correct code is very often within a few positions of it.
- J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
- J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
- J7327Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
- J7328Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
- J7329Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
- J7330Autologous cultured chondrocytes, implant
- J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
- J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
- J7335Capsaicin 8% patch, per 10 square centimetersterminated
- J7336Capsaicin 8% patch, per square centimeter
- J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
- J7342Instillation, ciprofloxacin otic suspension, 6 mg
- J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
- J7351Injection, bimatoprost, intracameral implant, 1 microgram
- J7352Afamelanotide implant, 1 mg
- J7353Anacaulase-bcdb, 8.8% gel, 1 gram
Questions about J7333
What is HCPCS code J7333?
J7333 is a HCPCS Level II code for hyaluronan or derivative, visco-3, for intra-articular injection, per dose. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7333?
The CMS HCPCS file marks J7333 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J7333 still valid?
No. J7333 was terminated on March 31, 2021 and should not be used on new claims.